• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WNS Announces Addition of Tim Main to Board of Directors

    5/18/21 4:15:00 PM ET
    $WNS
    $DGX
    $JBL
    $SHAC
    Real Estate
    Real Estate
    Medical Specialities
    Health Care
    Get the next $WNS alert in real time by email

    WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and growth to a $17+ billion, 100,000 employee organization through organic growth and strategic acquisitions. Tim is currently non-executive Chairman of the Board of Directors and a member of the Cyber Committee at Jabil. In addition, he serves on the Board of Quest Diagnostics (NYSE:DGX) as Chair of the Cybersecurity Committee and a member of the Audit & Finance and Governance committees, and on the Board of SCP & CO Healthcare Acquisition Co. (NASDAQ:SHAC), where he serves as a member of the Audit & Finance Committee.

    "Tim is a proven leader with a distinguished track record in international operations, corporate governance, vision and strategy, and technology-led growth," said Adrian T. Dillon, WNS's Chairman of the Board. "We are pleased to welcome Tim to the WNS Board of Directors, and believe that his experience guiding large organizations and developing talent will be a tremendous asset to the company."

    "The WNS team is delighted to add an experienced executive like Tim to our Board," said Keshav R. Murugesh, Chief Executive Officer of WNS. "His background in leading high-performing teams, driving both organic and inorganic revenue growth, and managing global operations will help WNS continue to generate exceptional value for all of our key stakeholders."

    About WNS

    WNS (Holdings) Limited (NYSE:WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer interaction services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of March 31, 2021, WNS had 43,997 professionals across 58 delivery centers worldwide including facilities in Australia, China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

    Safe Harbor Provision

    This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006071/en/

    Get the next $WNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WNS
    $DGX
    $JBL
    $SHAC

    CompanyDatePrice TargetRatingAnalyst
    Quest Diagnostics Incorporated
    $DGX
    8/25/2025$194.00Outperform → Neutral
    Robert W. Baird
    WNS (Holdings) Limited
    $WNS
    7/17/2025Hold
    Deutsche Bank
    Jabil Inc.
    $JBL
    7/2/2025$245.00Buy
    Stifel
    Jabil Inc.
    $JBL
    6/18/2025Hold → Buy
    Argus
    Quest Diagnostics Incorporated
    $DGX
    4/2/2025$195.00Buy
    Redburn Atlantic
    Quest Diagnostics Incorporated
    $DGX
    3/4/2025$185.00Buy → Neutral
    Citigroup
    Quest Diagnostics Incorporated
    $DGX
    1/6/2025$169.00 → $174.00Market Perform → Outperform
    Leerink Partners
    Quest Diagnostics Incorporated
    $DGX
    12/17/2024$145.00 → $172.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Chintapalli Anil bought $1,115,226 worth of shares (20,000 units at $55.76), increasing direct ownership by 72% to 47,900 units (SEC Form 4)

    4 - WNS (HOLDINGS) LTD (0001356570) (Issuer)

    6/2/25 4:41:04 PM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    SEC Filings

    View All

    SEC Form 424B5 filed by Jabil Inc.

    424B5 - JABIL INC (0000898293) (Filer)

    1/16/26 4:26:50 PM ET
    $JBL
    Electrical Products
    Technology

    SEC Form FWP filed by Jabil Inc.

    FWP - JABIL INC (0000898293) (Subject)

    1/14/26 5:03:02 PM ET
    $JBL
    Electrical Products
    Technology

    SEC Form 424B5 filed by Jabil Inc.

    424B5 - JABIL INC (0000898293) (Filer)

    1/14/26 8:50:03 AM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ansari Anousheh sold $246,000 worth of shares (1,000 units at $246.00), decreasing direct ownership by 3% to 33,900 units (SEC Form 4)

    4 - JABIL INC (0000898293) (Issuer)

    1/15/26 5:09:18 PM ET
    $JBL
    Electrical Products
    Technology

    Executive Chairman Mondello Mark T sold $5,515,417 worth of shares (22,800 units at $241.90), decreasing direct ownership by 2% to 1,128,659 units (SEC Form 4)

    4 - JABIL INC (0000898293) (Issuer)

    1/15/26 5:09:17 PM ET
    $JBL
    Electrical Products
    Technology

    Executive Chairman Mondello Mark T sold $4,724,941 worth of shares (20,000 units at $236.25), decreasing direct ownership by 2% to 1,151,459 units (SEC Form 4)

    4 - JABIL INC (0000898293) (Issuer)

    1/5/26 4:43:43 PM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect

    Jennifer Erickson succeeds longtime CEO David Dexter following more than 26 years of service PHOENIX, Jan. 15, 2026 /PRNewswire/ -- Sonora Quest Laboratories, together with its parent company Laboratory Sciences of Arizona (LSA), is pleased to announce the appointment of Jennifer Erickson as Chief Executive Officer-Elect. Erickson will take over from David Dexter, who is retiring this March after more than 26 years of leadership. Dexter joined Sonora Quest and LSA as president and CEO in 1999, where under his leadership, the company has grown tremendously, serving as the marke

    1/15/26 9:00:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

    SECAUCUS, N.J., Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast

    1/8/26 10:00:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quest Diagnostics downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Quest Diagnostics from Outperform to Neutral and set a new price target of $194.00

    8/25/25 8:10:20 AM ET
    $DGX
    Medical Specialities
    Health Care

    Deutsche Bank resumed coverage on WNS

    Deutsche Bank resumed coverage of WNS with a rating of Hold

    7/17/25 9:22:11 AM ET
    $WNS
    Real Estate

    Stifel resumed coverage on Jabil with a new price target

    Stifel resumed coverage of Jabil with a rating of Buy and set a new price target of $245.00

    7/2/25 7:57:22 AM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Leadership Updates

    Live Leadership Updates

    View All

    Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect

    Jennifer Erickson succeeds longtime CEO David Dexter following more than 26 years of service PHOENIX, Jan. 15, 2026 /PRNewswire/ -- Sonora Quest Laboratories, together with its parent company Laboratory Sciences of Arizona (LSA), is pleased to announce the appointment of Jennifer Erickson as Chief Executive Officer-Elect. Erickson will take over from David Dexter, who is retiring this March after more than 26 years of leadership. Dexter joined Sonora Quest and LSA as president and CEO in 1999, where under his leadership, the company has grown tremendously, serving as the marke

    1/15/26 9:00:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    Eos Energy Enterprises Appoints Industry Veteran John Mahaz as Chief Operating Officer to Drive Next Phase of Operational Growth in American-Made Energy Storage

    EDISON, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced the appointment of long-time operations leader, John Mahaz, as Chief Operating Officer (COO). Mahaz will lead the Company's operations, supply chain, and manufacturing strategy as Eos enters a critical phase of commercial scale-up. Mahaz joins Eos with more than three decades of experience in global manufacturing, operations, supply chain and business development from his

    8/18/25 8:00:00 AM ET
    $EOSE
    $JBL
    Industrial Machinery/Components
    Miscellaneous
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Financials

    Live finance-specific insights

    View All

    Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

    SECAUCUS, N.J., Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast

    1/8/26 10:00:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    Jabil Acquires Hanley Energy Group to Support AI Data Center Power Management

    Hanley Energy Group's system and energy optimization expertise will help expand Jabil's rack-level data center infrastructure capabilities Jabil Inc. (NYSE:JBL), a global leader in engineering, supply chain, and manufacturing solutions provider, today announced the successful acquisition of Hanley Energy Group, a provider of energy management and critical power solutions serving the data center infrastructure market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105130206/en/Hanley Energy Group designs, develops, supplies, installs, and commissions turnkey, mission-critical power and energy management solutions from the po

    1/5/26 8:05:00 AM ET
    $JBL
    Electrical Products
    Technology

    Jabil Posts First Quarter Results

    Raises Fiscal 2026 Outlook Today, Jabil Inc. (NYSE:JBL), reported preliminary, unaudited financial results for its first quarter of fiscal year 2026. First Quarter of Fiscal Year 2026 Highlights: Net revenue: $8.3 billion U.S. GAAP operating income: $283 million U.S. GAAP diluted earnings per share: $1.35 Core operating income (Non-GAAP): $454 million Core diluted earnings per share (Non-GAAP): $2.85 "Fiscal 2026 is off to an excellent start, with Q1 performance ahead of expectations across revenue, core operating margins, and core EPS," said CEO Mike Dastoor. "Our Intelligent Infrastructure segment remains a major growth engine, supported by accelerating demand across cloud,

    12/17/25 7:30:00 AM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Jabil Inc.

    SC 13G/A - JABIL INC (0000898293) (Subject)

    11/12/24 10:32:13 AM ET
    $JBL
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    11/1/24 4:27:50 PM ET
    $WNS
    Real Estate

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    7/10/24 10:10:34 AM ET
    $WNS
    Real Estate